![]()
- Obama says Boosting US Jobs is Top Priority
- More Consumers Giving 'Black Friday' the Cold Shoulder
- Prepare For Large Decline In Stocks, Next Year?
- Hewlett-Packard Earnings Rise, Match Guidance
- HP Comes in As Expected; Is It Time to Buy?
- Cramer: What Monday’s Housing Number Really Means
- Why the Dollar Will Likely Stay Weak for Some Time
- Bear, Lehman Execs Weren't Wiped Out by Crisis: Study
- How Real Estate Investors Skew Housing's Reality
- Can Murdoch Help Bing Challenge Google and Shift the Content Equation?
- HP's Mark Hurd
- HP Comes in As Expected; Is It Time to Buy?
- 9 Stocks That Play Rising Water Costs: Strategists
- Weis' Deal Likely Won't Change Big Money Contracts
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Nov. 23: Unusual Volume Leaders
- Help Wanted—Please Run $4 Billion University
- Apple Comes to AT&T's Rescue
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Why Amazon Rules Retail
- Wave of Debt Payments Facing US Government
- HP Comes in As Expected; Is It Time to Buy?
- JAL Slides to Record Low on Bankruptcy Jitters
- Prepare For Large Decline In Stocks, Next Year?
- Paul: Audit the Fed
- Hewlett-Packard Profit Rises, Matches Guidance
- Holiday Travel Outlook
- The Social Media Gaming Threat
CNBC.com
Stocks were lower in afternoon trading Wednesday as investors shrugged off some good news and worries about the recovery gripped the market.
And, the data today backed up those fears: New-home sales dropped 3.6 percent in September and August's gain was revised lower. Economists had expected sales to rise. That piled on to the bad news for the housing sector after an earlier report showed mortgage applications fall for the third week in a row last week.
And Goldman Sachs slashed its forecast for third-quarter GDP to 2.7 percent from 3 percent. The government's first read on Q3 GDP is due out on Thursday.
Investors shrugged off a report that showed durable-goods orders rose 1 percent in September, though compared to last year fell more than 24 percent.
The tech-heavy Nasdaq was the hardest hit of the three indexes as investors have begun to unwind some of their recovery trades in tech and consumer discretionary. Those sectors were among the hardest hit in yesterday's session.
The Nasdaq is now lower for October, though the Dow and S&P 500 are still higher for the month.
In afternoon trading, Alcoa, Caterpillar and GE were the biggest drags on the Dow. Telecoms AT&T and Verizon were at the top of the pack.
Oil fell, trading below $78 a barrel, after a report showed crude inventories rose by just 778,000 barrels last week. Economists had expected a 1.7 million build.
The Treasury's five-year auction today was met with decent demand but it wasn't as strong as the other auctions this week. Tomorrow is the seven-year auction.
On the earnings front, ConocoPhillips [AIG
Loading...
()
] reported a sharp drop in earnings and revenue from a year earlier but still beat expectations.
This came after Visa [AIG
Loading...
()
] beat on both earnings and revenue with its results after the bell Tuesday, and raised its dividend.
![]() |
Financials were among the day's biggest decliners following the disappointing housing news and as Pay Czar Kenneth Feinberg told a House panel that standards reached for executive pay at bailed-out firms should be applied to the broader marketplace. The bailed-out firms under review include AIG [AIG
Loading...
()
] , Bank of America [BAC
Loading...
()
] , Citigroup [C
Loading...
()
] , Chrysler, Chrysler Financial, General Motors, and GMAC.
A tale of two IPOs today: Vitamin Shoppe shares [VSI
Loading...
()
] soared after the vitamin chain's IPO priced above expectations. It's the first retailer to go public in two years. But Addus Homecare [ADUS
Loading...
()
] fell in its debut on the Nasdaq after pricing below expectations.
Apollo Group [APOL
Loading...
()
] dragged on the Nasdaq, tumbling more than 15 percent, as federal regulators opened a probe into the educational group's accounting and at least three brokerages downgraded the stock.
AstraZeneca [AZN-LN Loading... ()] shares fell as the company pulled its experimental lung-cancer drug Zactima from the regulatory submission process, after the drug demonstrated no survival advantage when added to chemotherapy.
Still to Come:
THURSDAY: 80th anniversary of 1929 market crash; Weekly jobless claims; first look at Q3 GDP; Larry Summers speaks in NYC; Earnings from AstraZeneca, ExxonMobil, P&G, Aetna, Kellogg, Motorola and Sprint Nextel
FRIDAY: Personal income and spending; consumer sentiment; Earnings from Chevron
Send comments to .
- The show attracts a big TV audience every year, but this year it may take on even more importance.
- …you'll want to be prepared. Tips for getting the most out of the post-Thanksgiving shopping frenzy.
- Congressman Ron Paul explains to Squawk Box why he’s pushing legislation to audit the Federal Reserve.
- CNBC’s Phil LeBeau took a test drive of GM’s flagship electric car. Here’s what he thought of the Volt.
- The energy company Power Efficiency is building tools that regulate the power electric motors use.
- CNBC’s technology reporter Jim Goldman guides you through the best gadgets to buy this holiday season.













